Applied Therapeutics Inc (APLT)
NASDAQ
The current APLT market cap is 873.99M. The company's latest EPS is USD -1.0428 and P/E is -7.36.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.66M | 0 | 0 | -667k | 190k |
Operating Income | -10.86M | -17.18M | -15.49M | -21.01M | -21.09M |
Net Income | -10.14M | -29.58M | -42.37M | -37.68M | -83.94M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 9.99M |
Operating Income | -45.58M | -94.47M | -105.62M | -82.95M | -64.54M |
Net Income | -45.51M | -93.96M | -105.58M | -82.51M | -119.76M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 30M | 43.65M | 45.2M | 54.83M | 151.23M |
Total Liabilities | 34.08M | 47.98M | 56.24M | 71.98M | 83.94M |
Total Equity | -4.07M | -4.33M | -11.04M | -17.15M | 67.29M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 48.39M | 104.51M | 89.89M | 38.36M | 54.83M |
Total Liabilities | 15.78M | 22.57M | 27.35M | 34.3M | 71.98M |
Total Equity | 32.61M | 81.94M | 62.54M | 4.06M | -17.15M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.99M | -23.44M | -38.17M | -55.17M | -18.91M |
Investing | 13.87M | 13.87M | 13.87M | 13.87M | N/A |
Financing | -622k | 28.53M | 45.1M | 74.54M | 115.5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -36.31M | -78.21M | -90.73M | -78.09M | -55.17M |
Investing | -20.01M | -19.47M | 12.43M | 13.17M | 13.87M |
Financing | 56.42M | 136.29M | 74.72M | 27.69M | 74.54M |
Market Cap | 873.99M |
Price to Earnings Ratio | -7.36 |
Price to Sales Ratio | 88.28 |
Price to Cash Ratio | 17.68 |
Price to Book Ratio | -51.44 |
Dividend Yield | - |
Shares Outstanding | 114.85M |
Average Volume (1 week) | 14.63M |
Average Volume (1 Month) | 4.62M |
52 Week Change | 179.78% |
52 Week High | 9.39 |
52 Week Low | 1.79 |
Spread (Intraday) | 0.16 (2.06%) |
Company Name | Applied Therapeutics Inc |
Address |
3411 silverside road tatnall wilmington, delaware 19810 |
Website | https://www.appliedtherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.